Oragenics, Inc.
OGEN
$0.183
$0.0084.57%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 48.84% | -96.79% | -62.59% | -61.55% | -44.56% |
| Total Depreciation and Amortization | -- | -100.00% | -90.08% | -66.11% | -38.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.44% | 2,526.49% | 2,088.62% | 1,445.24% | 1,448.18% |
| Change in Net Operating Assets | -27.90% | -2.45% | 82.43% | 1,001.44% | 217.55% |
| Cash from Operations | -17.92% | 10.90% | 33.78% | 29.52% | 52.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | 430.83% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -1,758.37% | -2,217.57% | -2,217.57% | -711.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -22.43% | -12.59% | -15.63% | -9.10% | -0.34% |
| Issuance of Common Stock | 685.02% | 625.71% | 5,147.47% | 3,779.51% | 1,126.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,006.66% | 1,509.72% | 758.84% | 542.72% | 157.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.03% | 67.96% | 55.02% | 41.98% | 49.85% |